Merck discontinues development of possible COVID-19 vaccines following results

Kenilworth-based Merck has announced the company is discontinuing development of its COVID-19 vaccine candidates, V590 and V591.

Source: Reuters: Health - January 25, 2021 Category: Consumer Health News Source Type: news